Novo Nordisk Halts Phase III Concizumab Hemophilia Trials After Three Thrombotic Events

 
• By Mandy Jackson
  
Hand above a red emergency button
Novo Nordisk halted three studies, including two Phase III trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D